Ani Pharmaceuticals (ANIP) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Ani Pharmaceuticals (ANIP) over the last 15 years, with Q3 2025 value amounting to -$20.3 million.
- Ani Pharmaceuticals' Other Gross PP&E Adjustments rose 145.3% to -$20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$142.0 million, marking a year-over-year decrease of 4679.71%. This contributed to the annual value of $100.6 million for FY2024, which is 2973.64% up from last year.
- According to the latest figures from Q3 2025, Ani Pharmaceuticals' Other Gross PP&E Adjustments is -$20.3 million, which was up 145.3% from -$40.7 million recorded in Q2 2025.
- In the past 5 years, Ani Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $100.6 million during Q4 2024, and its lowest value of -$60.3 million during Q1 2025.
- Its 5-year average for Other Gross PP&E Adjustments is $20.4 million, with a median of $32.1 million in 2023.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 3438.72% in 2022, then plummeted by 21799.06% in 2024.
- Ani Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $75.6 million in 2021, then grew by 0.44% to $76.0 million in 2022, then rose by 2.07% to $77.5 million in 2023, then rose by 29.74% to $100.6 million in 2024, then plummeted by 120.23% to -$20.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$20.3 million for Q3 2025, versus -$40.7 million for Q2 2025 and -$60.3 million for Q1 2025.